May 20, 2026 • 19 mins
A probiotic is supposed to help you recover after antibiotics. But what if the wrong probiotic acts like an invasive weed, moves into the empty real estate in your gut, and blocks your native microbiome from growing back? We unpack the science behind that unsettling possibility and use a comprehensive medical review by Dr. Kristen Glorioso to separate real microbiome research from gut health marketing that promises weight loss, brain fog cures, and “perfect” stool test scores.
We walk through why the gut microbiome is an ecosystem, not an arcade game. Some of the most important organisms are strict anaerobes that cannot survive oxygen, so they are not something you can reliably buy in a capsule. We explore why microbes like Akkermansia muciniphila and Prevotella copri can be helpful in one context and harmful in another, and how competitive nutrient exclusion explains why diversity can be protective. Then we zoom out to the “for whom” problem: genetics, ancestry, and age can shift what a healthy baseline looks like, including research tying APOE4 to lower butyrate producing bacteria and downstream effects on inflammation and the blood brain barrier.
From there, we get practical. We break down the post antibiotic study where a multi strain probiotic delayed recovery versus watchful waiting, why autologous fecal microbiota transplant can restore an ecosystem fast yet remains hard to implement, and what consistently works for most people: plant diversity like the 30 plants per week approach, whole foods that deliver fiber to the colon, live culture fermented foods, and aerobic exercise. We also clarify microbiome testing options, from 16S sequencing to shotgun metagenomics and metatranscriptomics, and how to use results to track change rather than chase a generic reference range.
If you want a smarter, calmer way to think about gut health, hit play, then subscribe, share this with a friend who loves probiotics, and leave a review with your biggest takeaway or question.
This podcast is created by Ai for educational and entertainment purposes only and does not constitute professional medical or health advice. Please talk to your healthcare team for medical advice.
Never miss an episode—subscribe on your favorite podcast app!
Listen
Watch
Mark as Played
Transcript
Episode Transcript
Available transcripts are automatically generated. Complete accuracy is not guaranteed.
SPEAKER_01 (00:00):
Imagine swallowing a pill that is, you know, supposed
to heal your gut after a roundof antibiotics, but instead it
actually acts like an invasiveweed.
Like it permanently blocks yourbody's natural ecosystem from
growing back.
SPEAKER_00 (00:13):
Yeah, it's a completely counterintuitive
concept.
SPEAKER_01 (00:16):
Right.
Today we are dismantling, well,basically everything you thought
you knew about probiotics.
If you've ever felt completelyoverwhelmed by the explosive
hype around gut microbiometesting, you know, those
targeted ads promising to fixyour weight, clear your brain
fog, and unlock longevity for acouple hundred bucks, this deep
dive is for you.
SPEAKER_00 (00:36):
Because the spaces move so incredibly fast.
Yeah.
I mean, distinguishing theactual science from the slick
marketing has become nearlyimpossible for most people.
SPEAKER_01 (00:44):
Exactly.
And to cut through all thatnoise, we are grounding our
conversation today in abrilliantly comprehensive 2026
article by Dr.
Kristen Glorioso, MD PhD.
It's titled Gut MicrobiomeImprovement for Health.
SPEAKER_00 (00:57):
It's a fantastic paper.
Yeah.
Really comprehensive.
SPEAKER_01 (01:00):
It is.
Our mission here isstraightforward, really.
We're going to explain what thescience actually says about the
organisms living inside you,reveal why obediently taking a
generic probiotic mightsometimes be a terrible idea,
and outline exactly how tointerpret test results and take
actionable steps.
So, okay, let's unpack this.
SPEAKER_00 (01:19):
Aaron Powell To start, I mean, we have to
fundamentally rethink how weview the gut.
Consumer marketing treats themicrobiome like a video game,
right?
SPEAKER_01 (01:27):
Like getting a high score.
SPEAKER_00 (01:28):
Aaron Powell Right, exactly.
Like you just stack up goodbacteria to get a high score and
zap the bad ones.
But biology operates like anecosystem, not an arcade game.
It requires balance,competition, and diversity.
SPEAKER_01 (01:40):
Aaron Powell And the text highlights a few heavy
hitters in this ecosystem thatdemonstrate this perfectly.
Take uh Fecalobacteriumprosnitzi.
SPEAKER_00 (01:48):
Oh, yeah, that's a major one.
SPEAKER_01 (01:49):
It's one of the most studied beneficial gut bacteria,
primarily because it's a massiveproducer of butyrate.
And butyrate is essentially thepreferred fuel source for the
cells lining your colon, right?
SPEAKER_00 (01:59):
Absolutely.
It keeps the barrier intact.
SPEAKER_01 (02:01):
And when researchers look across global cohorts, they
consistently find this specificbacterium is depleted in people
with inflammatory bowel disease,metabolic disease, obesity, and
even depression.
SPEAKER_00 (02:13):
Aaron Powell Which naturally leads people to wonder
well, why can't I just buy abottle of Faincalobacterium at
the pharmacy and take it?
SPEAKER_01 (02:20):
Right, just pop a pill.
SPEAKER_00 (02:21):
Exactly.
But the answer introduces acrucial group mentioned in Dr.
Glorioso's article, the strictanaerobes.
Organisms like Roseburiaintestinalis fall into this
category.
SPEAKER_01 (02:32):
Strict anaerobes, meaning they hate oxygen.
SPEAKER_00 (02:34):
The term literally means they are poisoned by
oxygen.
The moment they are exposed tothe air outside the gut, they
die.
You cannot package them into aconventional capsule sitting on
a CVS shelf.
SPEAKER_01 (02:46):
Oh wow.
So you literally can't take themas a probiotic pill.
SPEAKER_00 (02:49):
No, you can't.
The only way to increase theirnumbers is to farm them
internally by feeding themspecific dietary fibers.
SPEAKER_01 (02:56):
You have to cultivate the environment rather
than just dropping seeds.
Speaking of cultivating, the bugthat really caught my attention
in the source material is umAcromantia mucinifila.
SPEAKER_00 (03:06):
Ah, yes.
A really interesting microbe.
SPEAKER_01 (03:09):
Because it actually eats the mucus lining of your
gut.
It sounds like a bad thing,right?
Like an infection waiting tohappen, but it's actually, well,
it's like pruning a tree to makeit grow back stronger.
SPEAKER_00 (03:19):
That's a great way to put it.
By actively degrading thatmucus, it stimulates the goblet
cells in your gut to regeneratea thicker, healthier mucus
layer.
It strengthens the barrier byconstantly challenging it.
Which is wild.
It is.
But what's fascinating here ishow context dependent these
organisms are.
Acromancia is helpful in abalanced gut, but in a starved
(03:42):
gut, excessive mucus degradationcan actually become problematic.
SPEAKER_01 (03:47):
It starts eating too much at the house.
SPEAKER_00 (03:48):
Right.
And that nuance introduces theparadox of another bacterium
called prevotellicopri.
Early microbiome researchers sawhigh levels of previtella as the
ultimate marker of a healthyplant-rich diet.
SPEAKER_01 (04:01):
Because it's found in like rural populations,
right?
SPEAKER_00 (04:04):
Exactly.
It's highly abundant intraditional rural populations in
Africa and South America.
So we thought, hey, this is agood bug.
SPEAKER_01 (04:10):
But the word beneficial is a trap here, isn't
it?
SPEAKER_00 (04:13):
It really is.
Because more recent data showsthat when you look at Western
diets, certain strains of thatexact same species,
privotellocopri, are stronglyassociated with rheumatoid
arthritis and severe gutinflammation.
SPEAKER_01 (04:27):
Wait, really?
The exact same bug?
SPEAKER_00 (04:29):
The exact same species, yes.
The 2023 Oxford Science Paper,detailed in our source, explains
this shift through the conceptof competitive nutrient
exclusion.
SPEAKER_01 (04:40):
Okay, what does that mean in plain English?
SPEAKER_00 (04:42):
Basically, a diverse functional community of microbes
protects you from pathogenssimply by taking up all the
available physical space alongthe gut wall and eating all the
food.
SPEAKER_01 (04:51):
So there's no room for the bad guys.
SPEAKER_00 (04:53):
Right.
The more functional organismsyou have filling those niches,
the harder it is for a pathogenor an inflammatory strain of
brevitella to establish afoothold.
The neighborhood determines howthe individual microbes behave.
SPEAKER_01 (05:06):
Okay, so if a bacterium's impact changes
completely based on who you areand what the surrounding
neighborhood looks like, thentaking a consumer stool test and
comparing your results to ageneric reference range is
deeply flawed.
SPEAKER_00 (05:17):
It's highly problematic, yes.
SPEAKER_01 (05:19):
So comparing my gut to a standard reference range is
essentially like comparing mycar's engine to attractors.
They're built for entirelydifferent environments, right?
SPEAKER_00 (05:28):
Aaron Powell That is a perfect analogy.
Dr.
Glorioso actually calls this thefor whom problem.
The microbial composition thatlooks optimal for one person
could be highly inflammatory foranother.
Commercial reference ranges justgenerally fail to stratify for
your genetics, your ancestry, oryour long-term diet.
SPEAKER_01 (05:46):
Yeah, I was reading the 2025 Framingham Heart study
data in the text regarding theAPOE4 genotype, and the genetic
connection completely upends thestandard reference model.
SPEAKER_00 (05:57):
It really does.
APOE4 is the well-known genevariant associated with an
increased risk of Alzheimer'sdisease.
SPEAKER_01 (06:03):
Right.
And the data shows that APOE4carriers naturally harbor a much
lower abundance ofbutyrate-producing
anti-inflammatory bacteria, andthat's entirely independent of
how healthy their diet is.
SPEAKER_00 (06:13):
Exactly.
The genetic variant itselfactively shapes the local gut
environment.
And the mechanism behind whythis matters is critical.
With fewer butyrate-producingbacteria, less butyrate and
propionate make their way intothe bloodstream to reach the
brain.
SPEAKER_01 (06:26):
And the brain needs those, right?
It does.
SPEAKER_00 (06:29):
Those short chain fatty acids are essential for
maintaining the integrity of theblood-brain barrier.
When that barrier weakens due tolow butyrate, it amplifies
neuroinflammation.
SPEAKER_01 (06:40):
Oh, wow.
SPEAKER_00 (06:40):
Yeah, and that inflammation partially mediates
the accumulation of amyloidplaques in the brain, which
compounds the genetic risk forAlzheimer's.
SPEAKER_01 (06:49):
So your DNA alters your gut environment, which in
turn alters the physicalstructure of your brain.
SPEAKER_00 (06:56):
Yeah.
SPEAKER_01 (06:56):
That is staggering to think about.
SPEAKER_00 (06:57):
It's a completely interconnected system.
SPEAKER_01 (06:59):
And we see similar baseline shifts with ancestry
and age, right?
The source mentions indigenouspopulations like the Hadza in
Tanzania or the Yanomami in theAmazon, they carry organisms
like trepanema.
SPEAKER_00 (07:12):
Right, which is fascinating.
SPEAKER_01 (07:13):
Because a standard Western clinical test would flag
trepanema in red ink as adangerous pathogen.
SPEAKER_00 (07:18):
Oh, absolutely.
It would set off alarm bells.
But for these indigenouspopulations, it's an ancient,
stable gut resident.
It actually helps themmetabolize their massive intake
of fibrous tubers.
SPEAKER_01 (07:29):
So it's a helper for them, but a red flag on our
tests.
And age dictates the baselinejust as heavily, doesn't it?
SPEAKER_00 (07:36):
It does.
I mean, an infant's gut isnaturally dominated by
bifidobacterium.
That's because human breast milkcontains scagolized sugars,
human milk oligosaccharides thatevolve specifically to feed that
one bacterium.
SPEAKER_01 (07:50):
So a gut heavily dominated by a single organism
is perfectly healthy at sixmonths old.
SPEAKER_00 (07:55):
Exactly.
But if you saw that exact samemonolithic profile in a healthy
50-year-old, it would indicate aseverely compromised ecosystem.
Yet a lot of commercial testsjust lump everyone into a
generic pool of healthy adults.
SPEAKER_01 (08:08):
Which is wild.
So maintaining our uniquepersonalized baseline is the
whole game here.
Which makes me wonder whathappens when we drop a nuclear
bomb on that baseline.
SPEAKER_00 (08:17):
You mean antibiotics.
SPEAKER_01 (08:18):
I mean antibiotics.
Here's where it gets reallyinteresting.
Wait, so every time I obedientlytook a probiotic after my
antibiotics, I was actuallymaking things worse.
SPEAKER_00 (08:25):
According to the Weissman Institute study cited
in the source, yes.
Taking a multi-strainedprobiotic right after finishing
a round of antibiotics isactively harmful.
The intervention we've all beentold to do for decades actually
stalls recovery.
SPEAKER_01 (08:40):
That is mind-blowing.
Let's break down that 2018 cellstudy because it completely
disrupted the field.
SPEAKER_00 (08:46):
It really did.
So researchers took healthyadults, gave them a week of
broad spectrum antibiotics, andthen randomized them into three
groups.
Okay.
One group got a commercial11-strain probiotic.
Another group did watchfulwaiting, so taking nothing and
letting nature take its course.
Yeah.
And the third group received anautologous FMT.
SPEAKER_01 (09:06):
Which is a reinfusion of their own stool
that was banked before theantibiotics started, right?
SPEAKER_00 (09:10):
Exactly.
So let's look at what actuallyhappened inside their guts.
The antibiotics wiped out thecolonization resistance we just
talked about, that competitivenutrient exclusion.
SPEAKER_01 (09:18):
The neighborhood was totally emptied out.
SPEAKER_00 (09:20):
Right.
So when the probiotic groupswallowed those generic
commercial bacterial strains,those probiotic bugs found vast
tracts of empty real estatealong the gut lining and just
squatted there.
SPEAKER_01 (09:32):
They just moved right in.
SPEAKER_00 (09:33):
They colonized it unusually successfully.
And while that sounds positive,the probiotic strains actively
block the native microbiome fromreturning.
SPEAKER_01 (09:44):
Wait, really?
How?
SPEAKER_00 (09:45):
Well, lab experiments revealed that the
lactobacillus species in theprobiotic were secreting soluble
factors, essentially chemicalsignals, that directly inhibited
the native bacteria from growingback.
SPEAKER_01 (09:56):
So they were fighting off the original
residence.
SPEAKER_00 (09:59):
Exactly.
Fast forward five months, andthe mucosal reconstitution in
the probiotic group, meaning theprocess of the gut lining and
its native ecosystem repairingitself, was still significantly
worse than the watchful waitinggroup.
SPEAKER_01 (10:12):
The group that did nothing recovered better.
The probiotic acted like aninvasive weed that stopped the
native forest from regrowing.
SPEAKER_00 (10:19):
That's exactly what happened.
But the third group, the oneswho had their own pre-antibiotic
stool put back in, theyrecovered near completely within
days.
unknown (10:26):
Wow.
SPEAKER_01 (10:27):
Within days.
SPEAKER_00 (10:28):
Yeah.
And this raises an importantquestion about autologous FMT or
stool banking in mainstreammedicine.
It is biologically elegant,right?
You freeze a snapshot of youroptimal ecosystem and replant it
after the antibiotic fire.
SPEAKER_01 (10:42):
Yeah, that sounds like the perfect solution.
SPEAKER_00 (10:44):
But Dr.
Glorioso points out severepractical limitations.
You rarely know when you aregoing to get an unexpected sinus
infection, you know.
So timing the banking isincredibly difficult.
SPEAKER_01 (10:55):
So it seems like it would only make sense for a
planned heavy-duty intervention,like if you know it's coming.
SPEAKER_00 (11:00):
Exactly.
The clinical benefit for routineinfections just isn't there yet.
Currently, it really only makessense for planned procedures
that decimate the microbiome,like a bone marrow transplant,
not for like a standard courseof amoxicillin.
SPEAKER_01 (11:13):
Right, that makes sense.
So if generic probiotic pillsare largely a trap for healthy
adults recovering fromantibiotics, how do we
intentionally shape our gut?
SPEAKER_00 (11:22):
Well, the single most consistently supported
intervention across the entireevidence base is dietary fiber
and plant diversity.
SPEAKER_01 (11:29):
Okay, the 30-plant rule.
SPEAKER_00 (11:30):
Yes.
The data from the American GutProject pushes this.
Eating 30 or more differentplant species a week increases
microbial diversity, completelyindependent of the total weight
of the fiber you eat.
SPEAKER_01 (11:43):
So it's about the variety, not just eating 10
pounds of broccoli.
SPEAKER_00 (11:48):
Right.
Because different plantstructures rely on different
polysaccharides, which are justcomplex carbohydrates, and
different polyphenols.
And different microbesspecialize in breaking down
specific polysaccharides andpolyphenols.
SPEAKER_01 (12:01):
Okay, so can I just cheat and blend 50 plants into
one giant smoothie and chug iton a Monday?
SPEAKER_00 (12:07):
I wouldn't recommend it.
The mechanics of digestion makethat a bad idea.
When you pulverize 50 plants ina high-speed blender, you
completely obliterate the plantcell walls.
SPEAKER_01 (12:16):
Okay, but doesn't that make it easier to digest?
SPEAKER_00 (12:19):
It does, but you massively increase the surface
area of the food.
By doing that, you acceleratecarbohydrate absorption so much
that your upper gastrointestinaltract absorbs almost all the
nutrients before they ever reachthe colon.
SPEAKER_01 (12:31):
Oh, I see.
You end up starving the verybacteria you were trying to feed
because the food never makes itdown to them.
SPEAKER_00 (12:37):
Exactly.
You need whole foods.
So the complex structuressurvive the mechanical journey
to the lower gut.
The colon is where those strictanaerobes are waiting to ferment
those fibers.
SPEAKER_01 (12:47):
So chewing your plants instead of blending them
is key.
SPEAKER_00 (12:50):
Definitely.
SPEAKER_01 (12:51):
But what really stood out in the dietary section
was the data on fermented foods.
In a head-to-head match, theyactually beat fiber.
SPEAKER_00 (12:58):
Yeah, the 2021 trial out of Sanford was a landmark
moment for this.
Researchers randomizedparticipants to either a high
fiber diet or a high fermentedfood diet for 10 weeks.
SPEAKER_01 (13:09):
And what happened?
SPEAKER_00 (13:10):
The fermented food group eating items like kefir,
kimchi, and plain yogurt sawconsistent increases in overall
microbial diversity.
But more importantly, theyshowed significant reductions in
19 different inflammatoryproteins circulating in their
blood.
SPEAKER_01 (13:25):
That is incredible.
And I do need to jump in hereand clarify something for you
listening, because thesupermarket aisle is full of
traps.
We are talking strictly aboutlive culture fermented foods.
Those jars of perfectly uniformvinegar-soaked pickles sitting
on the warm supermarket shelf donot count.
SPEAKER_00 (13:39):
No, they don't.
If the ingredient list saysvinegar, it is a preserved food,
not a fermented one.
The bacteria are dead, or theywere never introduced in the
first place.
SPEAKER_01 (13:49):
You're just eating salty cucumbers.
SPEAKER_00 (13:51):
Right.
True fermented foods requirelive microorganisms doing the
work.
You're looking for refrigerated,lactofermented pickles made in
the saltwater brine or highquality kefir.
SPEAKER_01 (14:03):
Got it.
And the interventions aren'tlimited to diet either.
I want to talk about theexercise surprise.
Because we usually think ofaerobic exercise purely in terms
of, you know, burning caloriesor strengthening the heart.
SPEAKER_00 (14:16):
Right, the cardiovascular benefits.
SPEAKER_01 (14:18):
But the source notes that aerobic exercise
independently increasesacromansia, which means the
metabolic benefits of runningaren't just about burning
calories, but activelycultivating good bacteria.
SPEAKER_00 (14:29):
The mechanism there is a beautiful example of how
interconnected our systems are.
When you engage in sustainedaerobic exercise, you shift
blood flow away from the gut tothe muscles, you raise your core
body temperature and alter yourgut motility.
SPEAKER_01 (14:42):
Which is how fast things move through.
SPEAKER_00 (14:43):
Exactly.
These physiological stresssignals change the environment
in the colon, selectivelyfavoring metabolic powerhouses
like Acromanzia.
Your physical behaviors activelycurate the internal ecosystem.
SPEAKER_01 (14:58):
So now we know what to eat and how to move.
How do we actually measure ourprogress?
Because navigating the consumertesting market feels entirely
like the Wild West right now.
SPEAKER_00 (15:08):
It really is.
The confusion stems from thefact that the term microbiome
test covers severalfundamentally different
technologies.
Most of the cheaper consumertests use 16S sequencing.
SPEAKER_01 (15:19):
And that's the one that only reads down to the
genus level, right?
SPEAKER_00 (15:22):
Yes.
It's affordable, but it's likegetting someone's last name.
It tells you that you have lagdipacillus in your gut, but not
which specific member of thefamily.
SPEAKER_01 (15:30):
And as we saw with the Previtella Baradox, the
specific strain is thedifference between an organism
being a marker of a healthy dietor a driver of rheumatoid
arthritis.
SPEAKER_00 (15:39):
Exactly.
Then you have whole genomeshotgun sequencing, which is
more expensive but gets down tothe species and strain level,
the first and last name.
But the frontier of testing ismetatranscriptomic sequencing.
Instead of just looking at theDNA to see who is present in the
gut, it measures active RNA.
SPEAKER_01 (15:55):
Ah, so it's like reading their text messages to
see what they are actively doingat the exact moment you took the
sample.
SPEAKER_00 (16:01):
That's a great analogy.
And that is why you can send theexact same stool sample to two
different companies and getwildly different reports back.
They use different sequencingtechnology, they have completely
different blind spots, and theyare comparing your results
against entirely differentproprietary reference
populations.
SPEAKER_01 (16:18):
So what does this all mean for the listener?
If you have severegastrointestinal symptoms, the
text makes it clear you need toskip the consumer apps entirely,
right?
SPEAKER_00 (16:28):
Absolutely.
You need a clinical tier panelordered by a physician to look
for actual markers of disease,things like cowprotectin, which
indicates severe inflammation,or occult blood in the stool.
SPEAKER_01 (16:40):
But if you are generally healthy and just want
a baseline.
SPEAKER_00 (16:43):
Then consumer tests can be useful, provided you
treat them as a tracking toolrather than a medical diagnosis.
Test, intervene with targeteddiet or exercise, and then
retest in three to six months.
SPEAKER_01 (16:54):
Okay, so you test, intervene, and retest to see if
your intervention actually movedthe needle.
SPEAKER_00 (16:59):
Exactly.
And if we connect this to thebigger picture, the future of
the entire field is moving awayfrom single yogurt strains and
toward precision microbialtherapeutics.
SPEAKER_01 (17:09):
Like defined bacterial consortia.
SPEAKER_00 (17:11):
Right.
A prime example is a therapeuticcalled VE303.
It is a carefully selectedcombination of eight specific
Clostridius strains designed todo one specific job, reduce
recurrent C.
diff infections.
SPEAKER_01 (17:24):
It's like a tactical strike team of bacteria
engineered to fill a specificecological niche rather than
just throwing a multivitamin atthe wall to see what sticks.
SPEAKER_00 (17:33):
That's exactly what it is.
The other major leap will beidentifying superdonors for
fecal transplants.
SPEAKER_01 (17:39):
Superdonors.
SPEAKER_00 (17:39):
Yeah, some donors consistently produce
dramatically better clinicaloutcomes across multiple
recipients.
Figuring out exactly what makesa superdonor's microbial
ecosystem so robust is going tobe the key that unlocks FMT as a
mainstream therapeutic forcomplex diseases.
SPEAKER_01 (17:55):
It is incredible how fast the science is evolving.
To bring all of this together,gut health is clearly not a
generic numbers game.
It's about feeding your highlypersonalized internal ecosystem
with a vast variety of wholeplant shooting for those 30
different species a week, livefermented foods daily, and
aerobic exercise.
SPEAKER_00 (18:14):
Yes, that's the core of it.
SPEAKER_01 (18:16):
It honestly reminds me of a beautiful detail Dr.
Glorioso shared.
She fondly remembers thediverse, fresh buffet of fruits,
salads, and soups, the Ein Gettykibbets in Israel from her
childhood.
That kind of communal, variedwhole food eating is exactly
what this complex internalecosystem evolved to expect.
SPEAKER_00 (18:33):
It's the perfect diet for the diverse microbial
community we harbor.
SPEAKER_01 (18:36):
Before we wrap up, I want to leave you listening with
one final, slightly mind-bendingthought to mull over.
We've talked about how ourgenetics shape these microbes
and how these microbes in turnshape the physical structure of
our brains.
Right.
If we are currently learning howto design and deploy precision
bacterial consortia to activelymanage our anxiety, alter our
(18:57):
brain's amyloid plaque buildup,and control our metabolism, at
what point does you end and theybegin?
SPEAKER_00 (19:05):
It's a profound biological question.
SPEAKER_01 (19:07):
I mean, if our physical and mental health is
increasingly outsourced totrillions of alien microbes that
we have to manually program andcultivate with fiber and
exercise, are we the onesdriving the tractor?
Or are we just highly complexfarming vessels built by
evolution to carry our gut bugsaround?
Think about that the next timeyou go for a run to feed your
acromantia.
Thanks for joining us on thisdeep dive.
Imagine swallowing a pill that is, you know, supposed
to heal your gut after a roundof antibiotics, but instead it
actually acts like an invasiveweed.
Like it permanently blocks yourbody's natural ecosystem from
growing back.
SPEAKER_00 (00:13):
Yeah, it's a completely counterintuitive
concept.
SPEAKER_01 (00:16):
Right.
Today we are dismantling, well,basically everything you thought
you knew about probiotics.
If you've ever felt completelyoverwhelmed by the explosive
hype around gut microbiometesting, you know, those
targeted ads promising to fixyour weight, clear your brain
fog, and unlock longevity for acouple hundred bucks, this deep
dive is for you.
SPEAKER_00 (00:36):
Because the spaces move so incredibly fast.
Yeah.
I mean, distinguishing theactual science from the slick
marketing has become nearlyimpossible for most people.
SPEAKER_01 (00:44):
Exactly.
And to cut through all thatnoise, we are grounding our
conversation today in abrilliantly comprehensive 2026
article by Dr.
Kristen Glorioso, MD PhD.
It's titled Gut MicrobiomeImprovement for Health.
SPEAKER_00 (00:57):
It's a fantastic paper.
Yeah.
Really comprehensive.
SPEAKER_01 (01:00):
It is.
Our mission here isstraightforward, really.
We're going to explain what thescience actually says about the
organisms living inside you,reveal why obediently taking a
generic probiotic mightsometimes be a terrible idea,
and outline exactly how tointerpret test results and take
actionable steps.
So, okay, let's unpack this.
SPEAKER_00 (01:19):
Aaron Powell To start, I mean, we have to
fundamentally rethink how weview the gut.
Consumer marketing treats themicrobiome like a video game,
right?
SPEAKER_01 (01:27):
Like getting a high score.
SPEAKER_00 (01:28):
Aaron Powell Right, exactly.
Like you just stack up goodbacteria to get a high score and
zap the bad ones.
But biology operates like anecosystem, not an arcade game.
It requires balance,competition, and diversity.
SPEAKER_01 (01:40):
Aaron Powell And the text highlights a few heavy
hitters in this ecosystem thatdemonstrate this perfectly.
Take uh Fecalobacteriumprosnitzi.
SPEAKER_00 (01:48):
Oh, yeah, that's a major one.
SPEAKER_01 (01:49):
It's one of the most studied beneficial gut bacteria,
primarily because it's a massiveproducer of butyrate.
And butyrate is essentially thepreferred fuel source for the
cells lining your colon, right?
SPEAKER_00 (01:59):
Absolutely.
It keeps the barrier intact.
SPEAKER_01 (02:01):
And when researchers look across global cohorts, they
consistently find this specificbacterium is depleted in people
with inflammatory bowel disease,metabolic disease, obesity, and
even depression.
SPEAKER_00 (02:13):
Aaron Powell Which naturally leads people to wonder
well, why can't I just buy abottle of Faincalobacterium at
the pharmacy and take it?
SPEAKER_01 (02:20):
Right, just pop a pill.
SPEAKER_00 (02:21):
Exactly.
But the answer introduces acrucial group mentioned in Dr.
Glorioso's article, the strictanaerobes.
Organisms like Roseburiaintestinalis fall into this
category.
SPEAKER_01 (02:32):
Strict anaerobes, meaning they hate oxygen.
SPEAKER_00 (02:34):
The term literally means they are poisoned by
oxygen.
The moment they are exposed tothe air outside the gut, they
die.
You cannot package them into aconventional capsule sitting on
a CVS shelf.
SPEAKER_01 (02:46):
Oh wow.
So you literally can't take themas a probiotic pill.
SPEAKER_00 (02:49):
No, you can't.
The only way to increase theirnumbers is to farm them
internally by feeding themspecific dietary fibers.
SPEAKER_01 (02:56):
You have to cultivate the environment rather
than just dropping seeds.
Speaking of cultivating, the bugthat really caught my attention
in the source material is umAcromantia mucinifila.
SPEAKER_00 (03:06):
Ah, yes.
A really interesting microbe.
SPEAKER_01 (03:09):
Because it actually eats the mucus lining of your
gut.
It sounds like a bad thing,right?
Like an infection waiting tohappen, but it's actually, well,
it's like pruning a tree to makeit grow back stronger.
SPEAKER_00 (03:19):
That's a great way to put it.
By actively degrading thatmucus, it stimulates the goblet
cells in your gut to regeneratea thicker, healthier mucus
layer.
It strengthens the barrier byconstantly challenging it.
Which is wild.
It is.
But what's fascinating here ishow context dependent these
organisms are.
Acromancia is helpful in abalanced gut, but in a starved
(03:42):
gut, excessive mucus degradationcan actually become problematic.
SPEAKER_01 (03:47):
It starts eating too much at the house.
SPEAKER_00 (03:48):
Right.
And that nuance introduces theparadox of another bacterium
called prevotellicopri.
Early microbiome researchers sawhigh levels of previtella as the
ultimate marker of a healthyplant-rich diet.
SPEAKER_01 (04:01):
Because it's found in like rural populations,
right?
SPEAKER_00 (04:04):
Exactly.
It's highly abundant intraditional rural populations in
Africa and South America.
So we thought, hey, this is agood bug.
SPEAKER_01 (04:10):
But the word beneficial is a trap here, isn't
it?
SPEAKER_00 (04:13):
It really is.
Because more recent data showsthat when you look at Western
diets, certain strains of thatexact same species,
privotellocopri, are stronglyassociated with rheumatoid
arthritis and severe gutinflammation.
SPEAKER_01 (04:27):
Wait, really?
The exact same bug?
SPEAKER_00 (04:29):
The exact same species, yes.
The 2023 Oxford Science Paper,detailed in our source, explains
this shift through the conceptof competitive nutrient
exclusion.
SPEAKER_01 (04:40):
Okay, what does that mean in plain English?
SPEAKER_00 (04:42):
Basically, a diverse functional community of microbes
protects you from pathogenssimply by taking up all the
available physical space alongthe gut wall and eating all the
food.
SPEAKER_01 (04:51):
So there's no room for the bad guys.
SPEAKER_00 (04:53):
Right.
The more functional organismsyou have filling those niches,
the harder it is for a pathogenor an inflammatory strain of
brevitella to establish afoothold.
The neighborhood determines howthe individual microbes behave.
SPEAKER_01 (05:06):
Okay, so if a bacterium's impact changes
completely based on who you areand what the surrounding
neighborhood looks like, thentaking a consumer stool test and
comparing your results to ageneric reference range is
deeply flawed.
SPEAKER_00 (05:17):
It's highly problematic, yes.
SPEAKER_01 (05:19):
So comparing my gut to a standard reference range is
essentially like comparing mycar's engine to attractors.
They're built for entirelydifferent environments, right?
SPEAKER_00 (05:28):
Aaron Powell That is a perfect analogy.
Dr.
Glorioso actually calls this thefor whom problem.
The microbial composition thatlooks optimal for one person
could be highly inflammatory foranother.
Commercial reference ranges justgenerally fail to stratify for
your genetics, your ancestry, oryour long-term diet.
SPEAKER_01 (05:46):
Yeah, I was reading the 2025 Framingham Heart study
data in the text regarding theAPOE4 genotype, and the genetic
connection completely upends thestandard reference model.
SPEAKER_00 (05:57):
It really does.
APOE4 is the well-known genevariant associated with an
increased risk of Alzheimer'sdisease.
SPEAKER_01 (06:03):
Right.
And the data shows that APOE4carriers naturally harbor a much
lower abundance ofbutyrate-producing
anti-inflammatory bacteria, andthat's entirely independent of
how healthy their diet is.
SPEAKER_00 (06:13):
Exactly.
The genetic variant itselfactively shapes the local gut
environment.
And the mechanism behind whythis matters is critical.
With fewer butyrate-producingbacteria, less butyrate and
propionate make their way intothe bloodstream to reach the
brain.
SPEAKER_01 (06:26):
And the brain needs those, right?
It does.
SPEAKER_00 (06:29):
Those short chain fatty acids are essential for
maintaining the integrity of theblood-brain barrier.
When that barrier weakens due tolow butyrate, it amplifies
neuroinflammation.
SPEAKER_01 (06:40):
Oh, wow.
SPEAKER_00 (06:40):
Yeah, and that inflammation partially mediates
the accumulation of amyloidplaques in the brain, which
compounds the genetic risk forAlzheimer's.
SPEAKER_01 (06:49):
So your DNA alters your gut environment, which in
turn alters the physicalstructure of your brain.
SPEAKER_00 (06:56):
Yeah.
SPEAKER_01 (06:56):
That is staggering to think about.
SPEAKER_00 (06:57):
It's a completely interconnected system.
SPEAKER_01 (06:59):
And we see similar baseline shifts with ancestry
and age, right?
The source mentions indigenouspopulations like the Hadza in
Tanzania or the Yanomami in theAmazon, they carry organisms
like trepanema.
SPEAKER_00 (07:12):
Right, which is fascinating.
SPEAKER_01 (07:13):
Because a standard Western clinical test would flag
trepanema in red ink as adangerous pathogen.
SPEAKER_00 (07:18):
Oh, absolutely.
It would set off alarm bells.
But for these indigenouspopulations, it's an ancient,
stable gut resident.
It actually helps themmetabolize their massive intake
of fibrous tubers.
SPEAKER_01 (07:29):
So it's a helper for them, but a red flag on our
tests.
And age dictates the baselinejust as heavily, doesn't it?
SPEAKER_00 (07:36):
It does.
I mean, an infant's gut isnaturally dominated by
bifidobacterium.
That's because human breast milkcontains scagolized sugars,
human milk oligosaccharides thatevolve specifically to feed that
one bacterium.
SPEAKER_01 (07:50):
So a gut heavily dominated by a single organism
is perfectly healthy at sixmonths old.
SPEAKER_00 (07:55):
Exactly.
But if you saw that exact samemonolithic profile in a healthy
50-year-old, it would indicate aseverely compromised ecosystem.
Yet a lot of commercial testsjust lump everyone into a
generic pool of healthy adults.
SPEAKER_01 (08:08):
Which is wild.
So maintaining our uniquepersonalized baseline is the
whole game here.
Which makes me wonder whathappens when we drop a nuclear
bomb on that baseline.
SPEAKER_00 (08:17):
You mean antibiotics.
SPEAKER_01 (08:18):
I mean antibiotics.
Here's where it gets reallyinteresting.
Wait, so every time I obedientlytook a probiotic after my
antibiotics, I was actuallymaking things worse.
SPEAKER_00 (08:25):
According to the Weissman Institute study cited
in the source, yes.
Taking a multi-strainedprobiotic right after finishing
a round of antibiotics isactively harmful.
The intervention we've all beentold to do for decades actually
stalls recovery.
SPEAKER_01 (08:40):
That is mind-blowing.
Let's break down that 2018 cellstudy because it completely
disrupted the field.
SPEAKER_00 (08:46):
It really did.
So researchers took healthyadults, gave them a week of
broad spectrum antibiotics, andthen randomized them into three
groups.
Okay.
One group got a commercial11-strain probiotic.
Another group did watchfulwaiting, so taking nothing and
letting nature take its course.
Yeah.
And the third group received anautologous FMT.
SPEAKER_01 (09:06):
Which is a reinfusion of their own stool
that was banked before theantibiotics started, right?
SPEAKER_00 (09:10):
Exactly.
So let's look at what actuallyhappened inside their guts.
The antibiotics wiped out thecolonization resistance we just
talked about, that competitivenutrient exclusion.
SPEAKER_01 (09:18):
The neighborhood was totally emptied out.
SPEAKER_00 (09:20):
Right.
So when the probiotic groupswallowed those generic
commercial bacterial strains,those probiotic bugs found vast
tracts of empty real estatealong the gut lining and just
squatted there.
SPEAKER_01 (09:32):
They just moved right in.
SPEAKER_00 (09:33):
They colonized it unusually successfully.
And while that sounds positive,the probiotic strains actively
block the native microbiome fromreturning.
SPEAKER_01 (09:44):
Wait, really?
How?
SPEAKER_00 (09:45):
Well, lab experiments revealed that the
lactobacillus species in theprobiotic were secreting soluble
factors, essentially chemicalsignals, that directly inhibited
the native bacteria from growingback.
SPEAKER_01 (09:56):
So they were fighting off the original
residence.
SPEAKER_00 (09:59):
Exactly.
Fast forward five months, andthe mucosal reconstitution in
the probiotic group, meaning theprocess of the gut lining and
its native ecosystem repairingitself, was still significantly
worse than the watchful waitinggroup.
SPEAKER_01 (10:12):
The group that did nothing recovered better.
The probiotic acted like aninvasive weed that stopped the
native forest from regrowing.
SPEAKER_00 (10:19):
That's exactly what happened.
But the third group, the oneswho had their own pre-antibiotic
stool put back in, theyrecovered near completely within
days.
unknown (10:26):
Wow.
SPEAKER_01 (10:27):
Within days.
SPEAKER_00 (10:28):
Yeah.
And this raises an importantquestion about autologous FMT or
stool banking in mainstreammedicine.
It is biologically elegant,right?
You freeze a snapshot of youroptimal ecosystem and replant it
after the antibiotic fire.
SPEAKER_01 (10:42):
Yeah, that sounds like the perfect solution.
SPEAKER_00 (10:44):
But Dr.
Glorioso points out severepractical limitations.
You rarely know when you aregoing to get an unexpected sinus
infection, you know.
So timing the banking isincredibly difficult.
SPEAKER_01 (10:55):
So it seems like it would only make sense for a
planned heavy-duty intervention,like if you know it's coming.
SPEAKER_00 (11:00):
Exactly.
The clinical benefit for routineinfections just isn't there yet.
Currently, it really only makessense for planned procedures
that decimate the microbiome,like a bone marrow transplant,
not for like a standard courseof amoxicillin.
SPEAKER_01 (11:13):
Right, that makes sense.
So if generic probiotic pillsare largely a trap for healthy
adults recovering fromantibiotics, how do we
intentionally shape our gut?
SPEAKER_00 (11:22):
Well, the single most consistently supported
intervention across the entireevidence base is dietary fiber
and plant diversity.
SPEAKER_01 (11:29):
Okay, the 30-plant rule.
SPEAKER_00 (11:30):
Yes.
The data from the American GutProject pushes this.
Eating 30 or more differentplant species a week increases
microbial diversity, completelyindependent of the total weight
of the fiber you eat.
SPEAKER_01 (11:43):
So it's about the variety, not just eating 10
pounds of broccoli.
SPEAKER_00 (11:48):
Right.
Because different plantstructures rely on different
polysaccharides, which are justcomplex carbohydrates, and
different polyphenols.
And different microbesspecialize in breaking down
specific polysaccharides andpolyphenols.
SPEAKER_01 (12:01):
Okay, so can I just cheat and blend 50 plants into
one giant smoothie and chug iton a Monday?
SPEAKER_00 (12:07):
I wouldn't recommend it.
The mechanics of digestion makethat a bad idea.
When you pulverize 50 plants ina high-speed blender, you
completely obliterate the plantcell walls.
SPEAKER_01 (12:16):
Okay, but doesn't that make it easier to digest?
SPEAKER_00 (12:19):
It does, but you massively increase the surface
area of the food.
By doing that, you acceleratecarbohydrate absorption so much
that your upper gastrointestinaltract absorbs almost all the
nutrients before they ever reachthe colon.
SPEAKER_01 (12:31):
Oh, I see.
You end up starving the verybacteria you were trying to feed
because the food never makes itdown to them.
SPEAKER_00 (12:37):
Exactly.
You need whole foods.
So the complex structuressurvive the mechanical journey
to the lower gut.
The colon is where those strictanaerobes are waiting to ferment
those fibers.
SPEAKER_01 (12:47):
So chewing your plants instead of blending them
is key.
SPEAKER_00 (12:50):
Definitely.
SPEAKER_01 (12:51):
But what really stood out in the dietary section
was the data on fermented foods.
In a head-to-head match, theyactually beat fiber.
SPEAKER_00 (12:58):
Yeah, the 2021 trial out of Sanford was a landmark
moment for this.
Researchers randomizedparticipants to either a high
fiber diet or a high fermentedfood diet for 10 weeks.
SPEAKER_01 (13:09):
And what happened?
SPEAKER_00 (13:10):
The fermented food group eating items like kefir,
kimchi, and plain yogurt sawconsistent increases in overall
microbial diversity.
But more importantly, theyshowed significant reductions in
19 different inflammatoryproteins circulating in their
blood.
SPEAKER_01 (13:25):
That is incredible.
And I do need to jump in hereand clarify something for you
listening, because thesupermarket aisle is full of
traps.
We are talking strictly aboutlive culture fermented foods.
Those jars of perfectly uniformvinegar-soaked pickles sitting
on the warm supermarket shelf donot count.
SPEAKER_00 (13:39):
No, they don't.
If the ingredient list saysvinegar, it is a preserved food,
not a fermented one.
The bacteria are dead, or theywere never introduced in the
first place.
SPEAKER_01 (13:49):
You're just eating salty cucumbers.
SPEAKER_00 (13:51):
Right.
True fermented foods requirelive microorganisms doing the
work.
You're looking for refrigerated,lactofermented pickles made in
the saltwater brine or highquality kefir.
SPEAKER_01 (14:03):
Got it.
And the interventions aren'tlimited to diet either.
I want to talk about theexercise surprise.
Because we usually think ofaerobic exercise purely in terms
of, you know, burning caloriesor strengthening the heart.
SPEAKER_00 (14:16):
Right, the cardiovascular benefits.
SPEAKER_01 (14:18):
But the source notes that aerobic exercise
independently increasesacromansia, which means the
metabolic benefits of runningaren't just about burning
calories, but activelycultivating good bacteria.
SPEAKER_00 (14:29):
The mechanism there is a beautiful example of how
interconnected our systems are.
When you engage in sustainedaerobic exercise, you shift
blood flow away from the gut tothe muscles, you raise your core
body temperature and alter yourgut motility.
SPEAKER_01 (14:42):
Which is how fast things move through.
SPEAKER_00 (14:43):
Exactly.
These physiological stresssignals change the environment
in the colon, selectivelyfavoring metabolic powerhouses
like Acromanzia.
Your physical behaviors activelycurate the internal ecosystem.
SPEAKER_01 (14:58):
So now we know what to eat and how to move.
How do we actually measure ourprogress?
Because navigating the consumertesting market feels entirely
like the Wild West right now.
SPEAKER_00 (15:08):
It really is.
The confusion stems from thefact that the term microbiome
test covers severalfundamentally different
technologies.
Most of the cheaper consumertests use 16S sequencing.
SPEAKER_01 (15:19):
And that's the one that only reads down to the
genus level, right?
SPEAKER_00 (15:22):
Yes.
It's affordable, but it's likegetting someone's last name.
It tells you that you have lagdipacillus in your gut, but not
which specific member of thefamily.
SPEAKER_01 (15:30):
And as we saw with the Previtella Baradox, the
specific strain is thedifference between an organism
being a marker of a healthy dietor a driver of rheumatoid
arthritis.
SPEAKER_00 (15:39):
Exactly.
Then you have whole genomeshotgun sequencing, which is
more expensive but gets down tothe species and strain level,
the first and last name.
But the frontier of testing ismetatranscriptomic sequencing.
Instead of just looking at theDNA to see who is present in the
gut, it measures active RNA.
SPEAKER_01 (15:55):
Ah, so it's like reading their text messages to
see what they are actively doingat the exact moment you took the
sample.
SPEAKER_00 (16:01):
That's a great analogy.
And that is why you can send theexact same stool sample to two
different companies and getwildly different reports back.
They use different sequencingtechnology, they have completely
different blind spots, and theyare comparing your results
against entirely differentproprietary reference
populations.
SPEAKER_01 (16:18):
So what does this all mean for the listener?
If you have severegastrointestinal symptoms, the
text makes it clear you need toskip the consumer apps entirely,
right?
SPEAKER_00 (16:28):
Absolutely.
You need a clinical tier panelordered by a physician to look
for actual markers of disease,things like cowprotectin, which
indicates severe inflammation,or occult blood in the stool.
SPEAKER_01 (16:40):
But if you are generally healthy and just want
a baseline.
SPEAKER_00 (16:43):
Then consumer tests can be useful, provided you
treat them as a tracking toolrather than a medical diagnosis.
Test, intervene with targeteddiet or exercise, and then
retest in three to six months.
SPEAKER_01 (16:54):
Okay, so you test, intervene, and retest to see if
your intervention actually movedthe needle.
SPEAKER_00 (16:59):
Exactly.
And if we connect this to thebigger picture, the future of
the entire field is moving awayfrom single yogurt strains and
toward precision microbialtherapeutics.
SPEAKER_01 (17:09):
Like defined bacterial consortia.
SPEAKER_00 (17:11):
Right.
A prime example is a therapeuticcalled VE303.
It is a carefully selectedcombination of eight specific
Clostridius strains designed todo one specific job, reduce
recurrent C.
diff infections.
SPEAKER_01 (17:24):
It's like a tactical strike team of bacteria
engineered to fill a specificecological niche rather than
just throwing a multivitamin atthe wall to see what sticks.
SPEAKER_00 (17:33):
That's exactly what it is.
The other major leap will beidentifying superdonors for
fecal transplants.
SPEAKER_01 (17:39):
Superdonors.
SPEAKER_00 (17:39):
Yeah, some donors consistently produce
dramatically better clinicaloutcomes across multiple
recipients.
Figuring out exactly what makesa superdonor's microbial
ecosystem so robust is going tobe the key that unlocks FMT as a
mainstream therapeutic forcomplex diseases.
SPEAKER_01 (17:55):
It is incredible how fast the science is evolving.
To bring all of this together,gut health is clearly not a
generic numbers game.
It's about feeding your highlypersonalized internal ecosystem
with a vast variety of wholeplant shooting for those 30
different species a week, livefermented foods daily, and
aerobic exercise.
SPEAKER_00 (18:14):
Yes, that's the core of it.
SPEAKER_01 (18:16):
It honestly reminds me of a beautiful detail Dr.
Glorioso shared.
She fondly remembers thediverse, fresh buffet of fruits,
salads, and soups, the Ein Gettykibbets in Israel from her
childhood.
That kind of communal, variedwhole food eating is exactly
what this complex internalecosystem evolved to expect.
SPEAKER_00 (18:33):
It's the perfect diet for the diverse microbial
community we harbor.
SPEAKER_01 (18:36):
Before we wrap up, I want to leave you listening with
one final, slightly mind-bendingthought to mull over.
We've talked about how ourgenetics shape these microbes
and how these microbes in turnshape the physical structure of
our brains.
Right.
If we are currently learning howto design and deploy precision
bacterial consortia to activelymanage our anxiety, alter our
(18:57):
brain's amyloid plaque buildup,and control our metabolism, at
what point does you end and theybegin?
SPEAKER_00 (19:05):
It's a profound biological question.
SPEAKER_01 (19:07):
I mean, if our physical and mental health is
increasingly outsourced totrillions of alien microbes that
we have to manually program andcultivate with fiber and
exercise, are we the onesdriving the tractor?
Or are we just highly complexfarming vessels built by
evolution to carry our gut bugsaround?
Think about that the next timeyou go for a run to feed your
acromantia.
Thanks for joining us on thisdeep dive.
Popular Podcasts
Hey Jonas!
Hey Jonas! The official Jonas Brothers podcast. Hosted by Kevin, Joe, and Nick Jonas. It’s the Jonas Brothers you know... musicians, actors, and well, yes, brothers. Now, they’re sharing another side of themselves in the playful, intimate, and irreverent way only they can. Spend time with the Jonas Brothers here and stay a little bit longer for deep conversations like never before.
Stuff You Should Know
If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.
Dateline NBC
Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations. Follow now to get the latest episodes of Dateline NBC completely free, or subscribe to Dateline Premium for ad-free listening and exclusive bonus content: DatelinePremium.com